press_release_conclusion: Pregnant women would be willing to trial maternal growth factor gene therapy to treat severe early-onset fetal growth restriction (FGR) in their unborn babies, according to a new study. If the proposed trial goes ahead it is likely to be the first time maternal gene therapy has ever been used.
abstract_conclusion: This study did not identify any fundamental or insurmountable objections to a trial of maternal gene therapy for severe early-onset FGR.